Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DUVYZAT safely and effectively. See full prescribing information for DUVYZAT. DUVYZAT (givinostat) oral suspensionInitial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-prescription
DUVYZAT is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older.
- generic_name
- givinostat
- product_names
- givinostat
- ndc
- 11797-110, 11797-110-01, 11797-110-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en